Diabetic Macular Edema Severity at Diagnosis
NCT00886392 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118
Last updated 2009-04-22
Summary
The purpose of this study is to identify the severity level distribution at the moment of diagnosis, in diabetic patients with macular edema from a Mexico City sample, and to identify the rate with severe macular edema that needed immediate treatment.
Conditions
- Diabetes Mellitus
- Diabetic Retinopathy
- Macular Edema
Sponsors & Collaborators
-
Hospital Juarez de Mexico
lead OTHER_GOV
Principal Investigators
-
Patricia Muñoz Ibarra, MD · Hospital Juarez de Mexico
-
Dulce M Razo Blanco Hernandez, MD · Hospital Juarez de Mexico
-
Virgilio Lima Gomez, MD, MsC · Hospital Juarez de Mexico
Eligibility
- Min Age
- 40 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-06-30
- Primary Completion
- 2007-12-31
- Completion
- 2008-04-30
Countries
- Mexico
Study Locations
More Related Trials
-
Visual Function, Center Point Thickness and Macular Volume After Photocoagulation
NCT00906659 ·Status: COMPLETED
-
Diabetic Macular Edema: Relevance of Staging Progression on Therapeutic Outcome
NCT05080803 ·Status: COMPLETED
-
OCT-angiography in Diabetic Patients
NCT02870803 ·Status: UNKNOWN
-
Describing Patient With DME, Their Patient Journey and Disease Progression
NCT05966753 ·Status: COMPLETED
-
Home Monitoring of Diabetic Macular Edema
NCT05223569 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Vitrectomy for Diabetic Macular Edema
NCT00709319 ·Status: COMPLETED
-
Multimodal Image Study of Retinal Inflammation Markers After Corticoid and Antiangiogenic Treatment in Pacients With Diabetic Macular Edema
NCT03583242 ·Status: UNKNOWN
-
Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema
NCT05736081 ·Status: COMPLETED ·Phase: PHASE4
-
Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)
NCT01947881 ·Status: COMPLETED
-
Imaging Parameters and DME Treatment Response
NCT02637245 ·Status: COMPLETED
-
Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study
NCT00600301 ·Status: WITHDRAWN ·Phase: PHASE3
-
Intravitreal Ranibizumab Versus Its Combination With Dexamethasone in The Treatment of Diabetic Macular Edema
NCT05271539 ·Status: COMPLETED ·Phase: PHASE3
-
Identifying Patients With Unrecognized Treatable Diabetic Macular Edema
NCT01934920 ·Status: UNKNOWN
-
Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema
NCT01168258 ·Status: TERMINATED
-
Assessment of Color Vision in Diabetic Patients
NCT03345667 ·Status: COMPLETED
-
Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies
NCT00779142 ·Status: TERMINATED ·Phase: NA
-
Laser and Antioxidant Treatment of Diabetic Macular Edema
NCT00055042 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Dexamethasone on Reduction of Macular Thickness in Diabetic Patients, a Randomized Clinical Trial
NCT03608839 ·Status: COMPLETED ·Phase: PHASE2
-
Screening For Diabetic Macular Edema Among Diabetic Patients Using Optical Coherence Tomography
NCT03240458 ·Status: UNKNOWN
-
Computer Detection of Diabetic Retinopathy Compared to Clinical Examination
NCT01625598 ·Status: COMPLETED
-
Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)
NCT00536692 ·Status: COMPLETED ·Phase: PHASE2
-
Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography
NCT01790945 ·Status: UNKNOWN
-
Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser
NCT03590444 ·Status: COMPLETED ·Phase: PHASE4
-
Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema)
NCT00333671 ·Status: COMPLETED ·Phase: NA
-
Study on Exosome Changes in Patients With Proliferative Diabetic Retinopathy
NCT06198543 ·Status: NOT_YET_RECRUITING